Indications

• Non-Insulin Dependent Diabetes Mellitus (see Diabetes Mellitus)

---

Pharmacology

• Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor (see Sodium-Glucose Cotransporter-2 Inhibitors)

---

Administration

• xxxx

Dose Adjustment

• Hepatic
• Renal

---

Adverse Effects

Other Adverse Effects

• xxx
• xxx
• xxx

---

References

• xxxx